two things.. simple tape measure test as you say has been proven to be unreliable and gives false results.. ( PREVENT trial manuscript ) ... so that will go away as we progress.. to enable that change is why PB and her team are doing all the conferences, meetings, pod casts etc to get it known out there in medical land.. traction is happening from/with all of this ..
these actions are the base for getting it moving.. guidance was given last report of significant sales increase in US this qtr and rest of calendar 2025.. these results directly come from all of the above.. first time in Co history for any guidance
secondly.. from the above I anticipate June 4c to add to the positive financial trends that have occurred this FY.. we wait for the numbers to see details but I reference in particular changes to the cash receipts and ARR from Q1 to Q3 so far ( which have happened without any step change in sales so far ) .. plus cost controls that have been locked in.. trend is all moving in the right direction... every reduction in Qtr cash burn pushes out the runway and so it builds...
6 weeks and we will know ...
otherwise... I just did some more accumulation .. cheers all..
DYOR...
IPD Price at posting:
2.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)